Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Merck
Harvard Business School
McKesson
Boehringer Ingelheim

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076729

See Plans and Pricing

« Back to Dashboard

NDA 076729 describes TERIL, which is a drug marketed by Taro and is included in two NDAs. It is available from one supplier. Additional details are available on the TERIL profile page.

The generic ingredient in TERIL is carbamazepine. There are twenty-seven drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
Summary for 076729
Tradename:TERIL
Applicant:Taro
Ingredient:carbamazepine
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 076729
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TERIL carbamazepine SUSPENSION;ORAL 076729 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4047 51672-4047-9 450 mL in 1 BOTTLE (51672-4047-9)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength100MG/5ML
Approval Date:Sep 20, 2004TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Medtronic
Johnson and Johnson
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.